About this trial

The vestibular socket therapy was introduced by Elaskary et al that allowed immediate implant placement and total socket rehabilitation at the same time in class 2 compromised sockets , that showed supreme esthetic and functional predictability over 1,2,3 years of follow up, and showed minimal or no post restorative mid facial recession . The Vestibular socket therapy (VST) entails socket augmentation through a minimally invasive vestibular access incision to allow the delivery of the grafting components thus bypass the deleterious effect of the classic mucoperiosteal flap reflection as well as the deleterious effect of the delay approach, regardless of the degree of socket compromise \[6-8\].

Eligibility criteria

Qualifiers

Patients having a hopeless maxillary tooth in the esthetic region missing coronal tooth structure, type II socket (deficient labial plate of bone and intact overlying soft tissues), adequate palatal bone, ≥ 3 mm apical bone to engage the immediately placed implants, thereby achieving optimum primary stability (a minimum of 30 Ncm insertion torque) following tooth extraction.

Disqualifiers

Smokers, pregnant women, patients with systemic diseases, and history of chemotherapy or radiotherapy within the past 2 years.

Trial design

Treatments tested in this trial

  • control GBR
  • VST

Treatment groups

32 Participants
are divided into 2 treatment groups

Locations

3
The British university in Egypt CairoNew Cairo, Egypt
Faculty of oral and dental medicine the british university in egypt elsherouk Cairo Egypt
Faculty of oral and dental medicine the british university in egypt elsherouk Cairo Egypt

Sponsors and collaborators

British University In Egypt

Lead sponsor